Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $386.11 --0%
EPS Growth %: +5.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Herbalife board approves $250M share buyback over three years
- GE Aerospace to buy CPP for $11.75 billion in castings deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
